B of A Securities Maintains Underperform on Ardent Health, Raises Price Target to $14

Benzinga · 1d ago
B of A Securities analyst Kevin Fischbeck maintains Ardent Health (NYSE:ARDT) with a Underperform and raises the price target from $12 to $14.